Prevention and treatment of high-altitude illness in travelers

Current Infectious Disease Reports

Volumn 6, Issue 1, 2004, Pages 43-49

  Murdoch, David R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBONATE DEHYDRATASE INHIBITOR; DEXAMETHASONE; GINKGO BILOBA EXTRACT; NIFEDIPINE; PLACEBO; SPIRONOLACTONE; VITAMIN;

ACUTE DISEASE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; BRAIN EDEMA; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DISEASE SEVERITY; DIURESIS; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG MECHANISM; HUMAN; HYPERBARIC OXYGEN; LUNG EDEMA; PARESTHESIA; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; TRAVEL;

EID: 5444267495     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0023-4     Document Type: Review

References (49)

1. World Health Organization: World health statistics annual 1995. Geneva: World Health Organization; 1996.
2. Honigman B, Theis MK, Koziol-McLain J, et al.: Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993, 118:587-592.
3. Hackett PH, Rennie D, Levine HD: The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976, 2:1149-1155.
4. Hackett PH, Rennie D: Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am J Med 1979, 67:214-218.
5. Murdoch DR: Altitude illness among tourists flying to 3740 meters elevation in the Nepal Himalayas. J Travel Med 1995, 2:255-256.
6. Maggiorini M, Bühler B, Walter M, Oelz O: Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990, 301: 853-855.
7. Gabry AL, Ledoux X, Mozziconacci M, Martin C: High-altitude pulmonary edema at moderate altitude (<2,400 m; 7870 feet). A series of 52 patients. Chest 2003, 123:49-53.
8. Roach RC, Maes D, Sandoval D, et al.: Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 2000, 88:581-585.
9. Milledge JS, Beeley JM, Broome J, et al.: Acute mountain sickness susceptibility, fitness and hypoxic ventilatory response. Eur Respir J 1991, 4:1000-1003.
10. Bircher HP, Eichenberger U, Maggiorini M, et al.: Relationship of mountain sickness to physical fitness and exercise intensity during ascent. J Wilderness Med 1994, 5: 302-311.
11. Pollard AJ, Niermeyer S, Barry P, et al.: Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001. High Alt Med Biol 2001, 2:389-403.
12. Roach RC, Houston CS, Hongiman B, et al.: How well do older persons tolerate moderate altitude? West J Med 1995, 162:32-36.
13. Kayser B: Acute mountain sickness in western tourists around the Thorong pass (5400 in) in Nepal. J Wilderness Med 1991, 2:110-117.
14. Murdoch DR, Curry C: Acute mountain sickness in the Southern Alps of New Zealand. N Z Med 1998, 111:168-169.
15. Basnyat B: Neck irradiation or surgery may predispose to severe acute mountain sickness. J Travel Med 2002, 9:105.
16. Murdoch DR: Symptoms of infection and altitude illness among hikers in the Mount Everest region of Nepal. Aviat Space Environ Med 1995, 66:148-151.
17. Durmowicz AG, Noordeweir E, Nicholas R, Reeves JT: Inflammatory processes may predispose children to high-altitude pulmonary edema. J Pediatrics 1997, 130:838-840.
18. Silber E, Sonnenberg P, Collier DJ, et al.: Clinical features of headache at altitude: a prospective study. Neurology 2003, 60:1167-1171.
19. Hackett PH, Creagh CE, Grover RF, et al.: High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 1980, 302:1070-1073.
20. Naeije R, De Backer D, Vachiery JL, De Vuyst P: High-altitude pulmonary edema with primary pulmonary hypertension. Chest 1996, 110:286-289.
21. Vock P, Brutsche MH, Nanzer A, Bärtsch P: Variable radio-morphologic data of high altitude pulmonary edema. Features from 60 patients. Chest 1991, 100:1306-1311.
22. Basnyat B, Murdoch DR: High-altitude illness. Lancet 2003, 361:1967-1974.
23. Hackett PH: The cerebral etiology of high-altitude cerebral edema and acute mountain sickness. Wilderness Environ Med 1999, 10:97-109.
24. Roach RC, Hackett PH: Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 2001, 204:3161-3170.
25. Swenson ER, Maggiorini M, Mongovin S, et al.: Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002, 287:2228-2235.
26. Sartori C, Allemann Y, Duplain H, et al.: Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002, 346:1631-1636.
27. Murdoch DR: How fast is too fast? Attempts to define a recommended ascent rate to prevent acute mountain sickness. News Int Soc Mt Med 1999, 9:3-6.
28. Hackett PH, Roach RC: High-altitude illness. N Engl J Med 2001, 345:107-114.
29. Vann R, Pollock N, Pieper C, et al.: Epidemiological models of acute mountain sickness (AMS). High Alt Med Biol 2003, 4:451.
30. Basnyat B, Gertsch JH, Johnson W, et al.: Efficacy of low dose acetazolamide (125 mg bid) in the prophylaxis of acute mountain sickness. High Alt Med Biol 2003, 4:45-52.
31. Dumont L, Mardirosoff C, Tramèr MR: Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000, 321:267-272.
32. Hackett PH, Roach RC, Wood RA, et al.: Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 1988, 59:950-954.
33. Johnson TS, Rock PB, Fulco CS, et al.: Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984, 310:683-686.
34. Ellsworth AJ, Meyer EF, Larson EB: Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West J Med 1991, 154:289-293.
35. Ried LD, Carter KA, Ellsworth A: Acetazolamide or dexamethasone for prevention of acute mountain sickness: a meta-analysis. J Wilderness Med 1994, 5:34-48.
36. Bernhard WN, Schalick LM, Delaney PA, et al.: Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness. Aviat Space Environ Med 1998, 69:883-886.
37. Roncin JP, Schwartz F, D'Arbigny P: EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat Space Environ Med 1996, 67:445-452.
38. Leadbetter G, Maakestad K, Olson S, Hackett P: Gingko biloba reduces incidence and severity of acute mountain sickness. High Alt Med Biol 2001, 2:110.
39. Gertsch JH, Seto TB, Mor J, Onopa J: Gingko biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. High Alt Med Biol 2002, 3:29-37.
40. Bailey DM, Davies B: Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2001, 2:21-29.
41. Bärtsch P, Maggiorini M, Ritter M, et al.: Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991, 325:1284-1289.
42. Grissom CK, Roach RC, Sarnquist FH, Hackett PH: Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992, 116:461-465.
43. Levine BD, Yoshimura K, Kobayashi T, et al.: Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989, 321:1707-1713.
44. Ferrazzini G, Maggiorini M, Kriemler S, et al.: Successful treatment of acute mountain sickness with dexamethasone. BMJ 1987, 294:1380-1382.
45. Davis PR, Kippax J, Shaw GM, et al.: A novel continuous positive airways pressure (CPAP) device for use at high altitude. High Alt Med Biol 2002, 3:101.
46. Oelz O, Maggiorini M, Ritter M, et al.: Nifedipine for high altitude pulmonary oedema. Lancet 1989, 2: 1241-1244.
47. Kasic JF, Yaron M, Nicholas RA, et al.: Treatment of acute mountain sickness: hyperbaric versus oxygen therapy. Ann Emerg Med 1991, 20:1109-1112.
48. Bärtsch P, Merki B, Hofstetter D, et al.: Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ 1993, 306:1098-1101.
49. Keller HR, Maggiorini M, Bärtsch P, Oelz O: Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial. BMJ 1995, 310:1232-1235.